Loading…

IL‐17A contributes to HSV1 infection‐induced acute lung injury in a mouse model of pulmonary fibrosis

Background Patients with idiopathic pulmonary fibrosis (IPF) often experience acute exacerbation (AE) after an episode of common cold. Aims To establish a mouse model of virus infection‐induced AE‐IPF and investigate the mechanism underlying the AE‐IPF. Methods Herpes simplex virus 1 (HSV1) was inoc...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cellular and molecular medicine 2019-02, Vol.23 (2), p.908-919
Main Authors: Chen, Tao, Qiu, Hui, Zhao, Meng‐Meng, Chen, Shan‐Shan, Wu, Qin, Zhou, Nian‐Yu, Lu, Li‐Qin, Song, Jia‐Cui, Tang, Dan‐Li, Weng, Dong, Li, Hui‐Ping
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 919
container_issue 2
container_start_page 908
container_title Journal of cellular and molecular medicine
container_volume 23
creator Chen, Tao
Qiu, Hui
Zhao, Meng‐Meng
Chen, Shan‐Shan
Wu, Qin
Zhou, Nian‐Yu
Lu, Li‐Qin
Song, Jia‐Cui
Tang, Dan‐Li
Weng, Dong
Li, Hui‐Ping
description Background Patients with idiopathic pulmonary fibrosis (IPF) often experience acute exacerbation (AE) after an episode of common cold. Aims To establish a mouse model of virus infection‐induced AE‐IPF and investigate the mechanism underlying the AE‐IPF. Methods Herpes simplex virus 1 (HSV1) was inoculated intranasally to wild‐type (WT) and IL‐17A gene knockout (IL‐17A‐/‐) mice 21 days after intratracheal administration of bleomycin (BLM). Results HSV1 infection caused acute exacerbation in mice with BLM‐induced fibrosis. Compared with the BLM+Saline mice, the mice with BLM+HSV1 showed significantly higher acute lung injury (ALI) score (P 
doi_str_mv 10.1111/jcmm.13992
format article
fullrecord <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6349191</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JCMM13992</sourcerecordid><originalsourceid>FETCH-LOGICAL-p3442-10e16f22b1ea29e3870e67177887fe088bbd2552b65322f0c90acefcc92ab9d43</originalsourceid><addsrcrecordid>eNpVkUlOAzEQRS0EIiGw4QDIF0jw0IO9QYoiIEGJWDBsLdttB0fd7VYPoOw4AmfkJDgDEXjhKuk_f1X5A3CJ0QiHc73SRTHClHNyBPo4ZmQYcRod73vMKOuBs6ZZIUSTgJ2CHkU0ZSQmfeBm8-_PL5yOofZlWzvVtaaBrYfTp1cMXWmNbp0vA-PKrNMmg1IHBOZduQzyqqvXoUAJC981JtyZyaG3sOrywpcyqNap2jeuOQcnVuaNudjXAXi5u32eTIfzx_vZZDwfVjSKwrjI4MQSorCRhBvKUmSSFKcpY6k1iDGlMhLHRCUxJcQizZHUxmrNiVQ8i-gA3Ox8q04VJtMmrCVzUdWuCOMIL534r5TuTSz9u0hoxDHHweDqr8Hh5e-nBQDvgA-Xm_VBx0hs4hCbOMQ2DvEwWSy2Hf0B-HuBTA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>IL‐17A contributes to HSV1 infection‐induced acute lung injury in a mouse model of pulmonary fibrosis</title><source>Open Access: PubMed Central</source><source>Open Access: Wiley-Blackwell Open Access Journals</source><source>Publicly Available Content Database</source><creator>Chen, Tao ; Qiu, Hui ; Zhao, Meng‐Meng ; Chen, Shan‐Shan ; Wu, Qin ; Zhou, Nian‐Yu ; Lu, Li‐Qin ; Song, Jia‐Cui ; Tang, Dan‐Li ; Weng, Dong ; Li, Hui‐Ping</creator><creatorcontrib>Chen, Tao ; Qiu, Hui ; Zhao, Meng‐Meng ; Chen, Shan‐Shan ; Wu, Qin ; Zhou, Nian‐Yu ; Lu, Li‐Qin ; Song, Jia‐Cui ; Tang, Dan‐Li ; Weng, Dong ; Li, Hui‐Ping</creatorcontrib><description>Background Patients with idiopathic pulmonary fibrosis (IPF) often experience acute exacerbation (AE) after an episode of common cold. Aims To establish a mouse model of virus infection‐induced AE‐IPF and investigate the mechanism underlying the AE‐IPF. Methods Herpes simplex virus 1 (HSV1) was inoculated intranasally to wild‐type (WT) and IL‐17A gene knockout (IL‐17A‐/‐) mice 21 days after intratracheal administration of bleomycin (BLM). Results HSV1 infection caused acute exacerbation in mice with BLM‐induced fibrosis. Compared with the BLM+Saline mice, the mice with BLM+HSV1 showed significantly higher acute lung injury (ALI) score (P &lt; 0.0001), lower survival rate (100% vs 21.4%, P &lt; 0.0001), poorer lung function and higher inflammatory response representing by increased total inflammatory cells in bronchoalveolar lavage fluid (BALF) (P = 0.0323), increased proportion of Th17 cells in peripheral blood (P = 0.0004) and higher inflammatory factors in BALF. In addition, HSV1 infection increased the expression of endoplasmic reticulum stress (ERS)‐related proteins in mice with BLM‐induced fibrosis. The inhibition of ERS by tauroursodeoxycholic acid (TUDCA, an ERS inhibitor) significantly reduced the IL‐17A levels in BALF (P = 0.0140) and TH17 cells in the peripheral blood (P = 0.0084) of mice with BLM+HSV1, suggesting that suppression of ERS may reduce TH17 response in mice with AE‐IPF. Compared with WT mice with BLM+HSV1, IL‐17A‐/‐ mice with BLM+HSV1 had lower ALI score (P = 0.0119), higher survival rate (78.6% vs 21.4%, P = 0.004), improved lung function, and milder inflammatory response. Conclusions HSV1 infection in addition to BLM‐induced IPF can successfully establish AE‐IPF in mice. IL‐17A and ERS promote lung inflammation in AE‐IPF development.</description><identifier>ISSN: 1582-1838</identifier><identifier>EISSN: 1582-4934</identifier><identifier>DOI: 10.1111/jcmm.13992</identifier><identifier>PMID: 30378252</identifier><language>eng</language><publisher>England: John Wiley and Sons Inc</publisher><subject>acute exacerbations of idiopathic pulmonary fibrosis ; Acute Lung Injury - chemically induced ; Acute Lung Injury - drug therapy ; Acute Lung Injury - mortality ; Acute Lung Injury - virology ; Animals ; Anti-Inflammatory Agents - pharmacology ; Antiviral Agents - pharmacology ; Bleomycin ; Bronchoalveolar Lavage Fluid - chemistry ; Bronchoalveolar Lavage Fluid - immunology ; Disease Models, Animal ; endoplasmic reticulum stress ; Endoplasmic Reticulum Stress - drug effects ; Endoplasmic Reticulum Stress - genetics ; Endoplasmic Reticulum Stress - immunology ; Gene Expression ; Herpes Simplex - chemically induced ; Herpes Simplex - drug therapy ; Herpes Simplex - mortality ; Herpes Simplex - virology ; herpes simplex virus 1 ; Herpesvirus 1, Human ; Humans ; Idiopathic Pulmonary Fibrosis - chemically induced ; Idiopathic Pulmonary Fibrosis - drug therapy ; Idiopathic Pulmonary Fibrosis - mortality ; Idiopathic Pulmonary Fibrosis - virology ; Interleukin-17 - deficiency ; Interleukin-17 - genetics ; Interleukin-17 - immunology ; interleukin‐17A ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Original ; Respiratory Function Tests ; Survival Analysis ; Taurochenodeoxycholic Acid - pharmacology ; Th17 Cells - drug effects ; Th17 Cells - immunology ; Th17 Cells - virology</subject><ispartof>Journal of cellular and molecular medicine, 2019-02, Vol.23 (2), p.908-919</ispartof><rights>2018 The Authors. published by John Wiley &amp; Sons Ltd and Foundation for Cellular and Molecular Medicine.</rights><rights>2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley &amp; Sons Ltd and Foundation for Cellular and Molecular Medicine.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-6998-9828</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349191/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349191/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,733,786,790,891,11589,27957,27958,46087,46511,53827,53829</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30378252$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Tao</creatorcontrib><creatorcontrib>Qiu, Hui</creatorcontrib><creatorcontrib>Zhao, Meng‐Meng</creatorcontrib><creatorcontrib>Chen, Shan‐Shan</creatorcontrib><creatorcontrib>Wu, Qin</creatorcontrib><creatorcontrib>Zhou, Nian‐Yu</creatorcontrib><creatorcontrib>Lu, Li‐Qin</creatorcontrib><creatorcontrib>Song, Jia‐Cui</creatorcontrib><creatorcontrib>Tang, Dan‐Li</creatorcontrib><creatorcontrib>Weng, Dong</creatorcontrib><creatorcontrib>Li, Hui‐Ping</creatorcontrib><title>IL‐17A contributes to HSV1 infection‐induced acute lung injury in a mouse model of pulmonary fibrosis</title><title>Journal of cellular and molecular medicine</title><addtitle>J Cell Mol Med</addtitle><description>Background Patients with idiopathic pulmonary fibrosis (IPF) often experience acute exacerbation (AE) after an episode of common cold. Aims To establish a mouse model of virus infection‐induced AE‐IPF and investigate the mechanism underlying the AE‐IPF. Methods Herpes simplex virus 1 (HSV1) was inoculated intranasally to wild‐type (WT) and IL‐17A gene knockout (IL‐17A‐/‐) mice 21 days after intratracheal administration of bleomycin (BLM). Results HSV1 infection caused acute exacerbation in mice with BLM‐induced fibrosis. Compared with the BLM+Saline mice, the mice with BLM+HSV1 showed significantly higher acute lung injury (ALI) score (P &lt; 0.0001), lower survival rate (100% vs 21.4%, P &lt; 0.0001), poorer lung function and higher inflammatory response representing by increased total inflammatory cells in bronchoalveolar lavage fluid (BALF) (P = 0.0323), increased proportion of Th17 cells in peripheral blood (P = 0.0004) and higher inflammatory factors in BALF. In addition, HSV1 infection increased the expression of endoplasmic reticulum stress (ERS)‐related proteins in mice with BLM‐induced fibrosis. The inhibition of ERS by tauroursodeoxycholic acid (TUDCA, an ERS inhibitor) significantly reduced the IL‐17A levels in BALF (P = 0.0140) and TH17 cells in the peripheral blood (P = 0.0084) of mice with BLM+HSV1, suggesting that suppression of ERS may reduce TH17 response in mice with AE‐IPF. Compared with WT mice with BLM+HSV1, IL‐17A‐/‐ mice with BLM+HSV1 had lower ALI score (P = 0.0119), higher survival rate (78.6% vs 21.4%, P = 0.004), improved lung function, and milder inflammatory response. Conclusions HSV1 infection in addition to BLM‐induced IPF can successfully establish AE‐IPF in mice. IL‐17A and ERS promote lung inflammation in AE‐IPF development.</description><subject>acute exacerbations of idiopathic pulmonary fibrosis</subject><subject>Acute Lung Injury - chemically induced</subject><subject>Acute Lung Injury - drug therapy</subject><subject>Acute Lung Injury - mortality</subject><subject>Acute Lung Injury - virology</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Antiviral Agents - pharmacology</subject><subject>Bleomycin</subject><subject>Bronchoalveolar Lavage Fluid - chemistry</subject><subject>Bronchoalveolar Lavage Fluid - immunology</subject><subject>Disease Models, Animal</subject><subject>endoplasmic reticulum stress</subject><subject>Endoplasmic Reticulum Stress - drug effects</subject><subject>Endoplasmic Reticulum Stress - genetics</subject><subject>Endoplasmic Reticulum Stress - immunology</subject><subject>Gene Expression</subject><subject>Herpes Simplex - chemically induced</subject><subject>Herpes Simplex - drug therapy</subject><subject>Herpes Simplex - mortality</subject><subject>Herpes Simplex - virology</subject><subject>herpes simplex virus 1</subject><subject>Herpesvirus 1, Human</subject><subject>Humans</subject><subject>Idiopathic Pulmonary Fibrosis - chemically induced</subject><subject>Idiopathic Pulmonary Fibrosis - drug therapy</subject><subject>Idiopathic Pulmonary Fibrosis - mortality</subject><subject>Idiopathic Pulmonary Fibrosis - virology</subject><subject>Interleukin-17 - deficiency</subject><subject>Interleukin-17 - genetics</subject><subject>Interleukin-17 - immunology</subject><subject>interleukin‐17A</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Original</subject><subject>Respiratory Function Tests</subject><subject>Survival Analysis</subject><subject>Taurochenodeoxycholic Acid - pharmacology</subject><subject>Th17 Cells - drug effects</subject><subject>Th17 Cells - immunology</subject><subject>Th17 Cells - virology</subject><issn>1582-1838</issn><issn>1582-4934</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><recordid>eNpVkUlOAzEQRS0EIiGw4QDIF0jw0IO9QYoiIEGJWDBsLdttB0fd7VYPoOw4AmfkJDgDEXjhKuk_f1X5A3CJ0QiHc73SRTHClHNyBPo4ZmQYcRod73vMKOuBs6ZZIUSTgJ2CHkU0ZSQmfeBm8-_PL5yOofZlWzvVtaaBrYfTp1cMXWmNbp0vA-PKrNMmg1IHBOZduQzyqqvXoUAJC981JtyZyaG3sOrywpcyqNap2jeuOQcnVuaNudjXAXi5u32eTIfzx_vZZDwfVjSKwrjI4MQSorCRhBvKUmSSFKcpY6k1iDGlMhLHRCUxJcQizZHUxmrNiVQ8i-gA3Ox8q04VJtMmrCVzUdWuCOMIL534r5TuTSz9u0hoxDHHweDqr8Hh5e-nBQDvgA-Xm_VBx0hs4hCbOMQ2DvEwWSy2Hf0B-HuBTA</recordid><startdate>201902</startdate><enddate>201902</enddate><creator>Chen, Tao</creator><creator>Qiu, Hui</creator><creator>Zhao, Meng‐Meng</creator><creator>Chen, Shan‐Shan</creator><creator>Wu, Qin</creator><creator>Zhou, Nian‐Yu</creator><creator>Lu, Li‐Qin</creator><creator>Song, Jia‐Cui</creator><creator>Tang, Dan‐Li</creator><creator>Weng, Dong</creator><creator>Li, Hui‐Ping</creator><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6998-9828</orcidid></search><sort><creationdate>201902</creationdate><title>IL‐17A contributes to HSV1 infection‐induced acute lung injury in a mouse model of pulmonary fibrosis</title><author>Chen, Tao ; Qiu, Hui ; Zhao, Meng‐Meng ; Chen, Shan‐Shan ; Wu, Qin ; Zhou, Nian‐Yu ; Lu, Li‐Qin ; Song, Jia‐Cui ; Tang, Dan‐Li ; Weng, Dong ; Li, Hui‐Ping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p3442-10e16f22b1ea29e3870e67177887fe088bbd2552b65322f0c90acefcc92ab9d43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>acute exacerbations of idiopathic pulmonary fibrosis</topic><topic>Acute Lung Injury - chemically induced</topic><topic>Acute Lung Injury - drug therapy</topic><topic>Acute Lung Injury - mortality</topic><topic>Acute Lung Injury - virology</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Antiviral Agents - pharmacology</topic><topic>Bleomycin</topic><topic>Bronchoalveolar Lavage Fluid - chemistry</topic><topic>Bronchoalveolar Lavage Fluid - immunology</topic><topic>Disease Models, Animal</topic><topic>endoplasmic reticulum stress</topic><topic>Endoplasmic Reticulum Stress - drug effects</topic><topic>Endoplasmic Reticulum Stress - genetics</topic><topic>Endoplasmic Reticulum Stress - immunology</topic><topic>Gene Expression</topic><topic>Herpes Simplex - chemically induced</topic><topic>Herpes Simplex - drug therapy</topic><topic>Herpes Simplex - mortality</topic><topic>Herpes Simplex - virology</topic><topic>herpes simplex virus 1</topic><topic>Herpesvirus 1, Human</topic><topic>Humans</topic><topic>Idiopathic Pulmonary Fibrosis - chemically induced</topic><topic>Idiopathic Pulmonary Fibrosis - drug therapy</topic><topic>Idiopathic Pulmonary Fibrosis - mortality</topic><topic>Idiopathic Pulmonary Fibrosis - virology</topic><topic>Interleukin-17 - deficiency</topic><topic>Interleukin-17 - genetics</topic><topic>Interleukin-17 - immunology</topic><topic>interleukin‐17A</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Original</topic><topic>Respiratory Function Tests</topic><topic>Survival Analysis</topic><topic>Taurochenodeoxycholic Acid - pharmacology</topic><topic>Th17 Cells - drug effects</topic><topic>Th17 Cells - immunology</topic><topic>Th17 Cells - virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Tao</creatorcontrib><creatorcontrib>Qiu, Hui</creatorcontrib><creatorcontrib>Zhao, Meng‐Meng</creatorcontrib><creatorcontrib>Chen, Shan‐Shan</creatorcontrib><creatorcontrib>Wu, Qin</creatorcontrib><creatorcontrib>Zhou, Nian‐Yu</creatorcontrib><creatorcontrib>Lu, Li‐Qin</creatorcontrib><creatorcontrib>Song, Jia‐Cui</creatorcontrib><creatorcontrib>Tang, Dan‐Li</creatorcontrib><creatorcontrib>Weng, Dong</creatorcontrib><creatorcontrib>Li, Hui‐Ping</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>Wiley Online Library</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of cellular and molecular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Tao</au><au>Qiu, Hui</au><au>Zhao, Meng‐Meng</au><au>Chen, Shan‐Shan</au><au>Wu, Qin</au><au>Zhou, Nian‐Yu</au><au>Lu, Li‐Qin</au><au>Song, Jia‐Cui</au><au>Tang, Dan‐Li</au><au>Weng, Dong</au><au>Li, Hui‐Ping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>IL‐17A contributes to HSV1 infection‐induced acute lung injury in a mouse model of pulmonary fibrosis</atitle><jtitle>Journal of cellular and molecular medicine</jtitle><addtitle>J Cell Mol Med</addtitle><date>2019-02</date><risdate>2019</risdate><volume>23</volume><issue>2</issue><spage>908</spage><epage>919</epage><pages>908-919</pages><issn>1582-1838</issn><eissn>1582-4934</eissn><notes>Tao Chen, Hui Qiu and Meng‐Meng Zhao contributed equally to this work.</notes><abstract>Background Patients with idiopathic pulmonary fibrosis (IPF) often experience acute exacerbation (AE) after an episode of common cold. Aims To establish a mouse model of virus infection‐induced AE‐IPF and investigate the mechanism underlying the AE‐IPF. Methods Herpes simplex virus 1 (HSV1) was inoculated intranasally to wild‐type (WT) and IL‐17A gene knockout (IL‐17A‐/‐) mice 21 days after intratracheal administration of bleomycin (BLM). Results HSV1 infection caused acute exacerbation in mice with BLM‐induced fibrosis. Compared with the BLM+Saline mice, the mice with BLM+HSV1 showed significantly higher acute lung injury (ALI) score (P &lt; 0.0001), lower survival rate (100% vs 21.4%, P &lt; 0.0001), poorer lung function and higher inflammatory response representing by increased total inflammatory cells in bronchoalveolar lavage fluid (BALF) (P = 0.0323), increased proportion of Th17 cells in peripheral blood (P = 0.0004) and higher inflammatory factors in BALF. In addition, HSV1 infection increased the expression of endoplasmic reticulum stress (ERS)‐related proteins in mice with BLM‐induced fibrosis. The inhibition of ERS by tauroursodeoxycholic acid (TUDCA, an ERS inhibitor) significantly reduced the IL‐17A levels in BALF (P = 0.0140) and TH17 cells in the peripheral blood (P = 0.0084) of mice with BLM+HSV1, suggesting that suppression of ERS may reduce TH17 response in mice with AE‐IPF. Compared with WT mice with BLM+HSV1, IL‐17A‐/‐ mice with BLM+HSV1 had lower ALI score (P = 0.0119), higher survival rate (78.6% vs 21.4%, P = 0.004), improved lung function, and milder inflammatory response. Conclusions HSV1 infection in addition to BLM‐induced IPF can successfully establish AE‐IPF in mice. IL‐17A and ERS promote lung inflammation in AE‐IPF development.</abstract><cop>England</cop><pub>John Wiley and Sons Inc</pub><pmid>30378252</pmid><doi>10.1111/jcmm.13992</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-6998-9828</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1582-1838
ispartof Journal of cellular and molecular medicine, 2019-02, Vol.23 (2), p.908-919
issn 1582-1838
1582-4934
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6349191
source Open Access: PubMed Central; Open Access: Wiley-Blackwell Open Access Journals; Publicly Available Content Database
subjects acute exacerbations of idiopathic pulmonary fibrosis
Acute Lung Injury - chemically induced
Acute Lung Injury - drug therapy
Acute Lung Injury - mortality
Acute Lung Injury - virology
Animals
Anti-Inflammatory Agents - pharmacology
Antiviral Agents - pharmacology
Bleomycin
Bronchoalveolar Lavage Fluid - chemistry
Bronchoalveolar Lavage Fluid - immunology
Disease Models, Animal
endoplasmic reticulum stress
Endoplasmic Reticulum Stress - drug effects
Endoplasmic Reticulum Stress - genetics
Endoplasmic Reticulum Stress - immunology
Gene Expression
Herpes Simplex - chemically induced
Herpes Simplex - drug therapy
Herpes Simplex - mortality
Herpes Simplex - virology
herpes simplex virus 1
Herpesvirus 1, Human
Humans
Idiopathic Pulmonary Fibrosis - chemically induced
Idiopathic Pulmonary Fibrosis - drug therapy
Idiopathic Pulmonary Fibrosis - mortality
Idiopathic Pulmonary Fibrosis - virology
Interleukin-17 - deficiency
Interleukin-17 - genetics
Interleukin-17 - immunology
interleukin‐17A
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Original
Respiratory Function Tests
Survival Analysis
Taurochenodeoxycholic Acid - pharmacology
Th17 Cells - drug effects
Th17 Cells - immunology
Th17 Cells - virology
title IL‐17A contributes to HSV1 infection‐induced acute lung injury in a mouse model of pulmonary fibrosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-30T12%3A32%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=IL%E2%80%9017A%20contributes%20to%20HSV1%20infection%E2%80%90induced%20acute%20lung%20injury%20in%20a%20mouse%20model%20of%20pulmonary%20fibrosis&rft.jtitle=Journal%20of%20cellular%20and%20molecular%20medicine&rft.au=Chen,%20Tao&rft.date=2019-02&rft.volume=23&rft.issue=2&rft.spage=908&rft.epage=919&rft.pages=908-919&rft.issn=1582-1838&rft.eissn=1582-4934&rft_id=info:doi/10.1111/jcmm.13992&rft_dat=%3Cwiley_pubme%3EJCMM13992%3C/wiley_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p3442-10e16f22b1ea29e3870e67177887fe088bbd2552b65322f0c90acefcc92ab9d43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/30378252&rfr_iscdi=true